Skip to main content
. Author manuscript; available in PMC: 2014 Jun 15.
Published in final edited form as: Clin Cancer Res. 2013 May 1;19(12):3268–3275. doi: 10.1158/1078-0432.CCR-12-3496

Table 1.

Clinical risk assessment criteria

Study Group Case Definitions
Low Risk
for malignancy
Leukoplakia. Adherent white patch on any oral mucosal surface
which has no apparent explanation or etiology (i.e., frictional
trauma, infection). Such lesions will NOT have associated
erythroplakia, ulceration, erosion, or submucosal extension /
induration.
High Risk
for malignancy
Any of the following features, alone or in combination. May be
associated with other high-risk signs and symptoms such as history
of oral cancer or other cancer with metastatic potential, regional
adenopathy, submucosal extension / induration, ulceration.
Leukoplakia Any adherent white patch on any oral mucosal surface
which has no apparent explanation or etiology but DOES HAVE
associated, ulceration, erosion, or submucosal extension /
induration..
Erythroplakia: Red patch on any mucosal surface which has no
apparent explanation or etiology.
Erythroleukoplakia: Mixed red and white patch on any oral mucosal
surface which has no apparent explanation or etiology
Ulceration: Any break in the oral epithelial surface which has no
apparent explanation or etiology. This may or may not be
symptomatic and may be of undetermined duration. There is
increased risk for malignancy with increased duration.
Known Cancer Biopsy-proven oral squamous cell carcinoma prior to study
enrollment